Table 4 Optimal fold-change cutoffs denoting the strongest correlation between microRNA expression and LN status in histologic grade 1–2 EC primary tumor specimens

From: Identification of microRNA expression profile related to lymph node status in women with early-stage grade 1–2 endometrial cancer

 

EC FFPE primary tumor Negative LN N=27

EC FFPE primary tumor Positive LN N=9

P-value

miR-375

   

 FC>0.30

20 (95.2%)

1 (4.8%)

0.001

 FC<0.30

7 (46.7%)

8 (53.3%)

 

miR-184

   

 FC>0.30

23 (88.5%)

3 (11.5%)

0.006

 FC<0.30

4 (40.0%)

6 (60.0%)

 

miR-34c-5p

   

 FC>0.0852

18 (90.0%)

2 (10.0%)

0.049

 FC<0.0852

9 (56.3%)

7 (43.7%)

 

miR-34b-5p

   

 FC>0.09

23 (85.2%)

4 (14.8%)

0.026

 FC<0.09

4 (44.4%)

5 (55.6%)

 

miR-148a-3p

   

 FC>0.50

22 (88.0%)

3 (12.0%)

0.012

 FC<0.50

5 (45.5%)

6 (54.5%)

 

miR-129-5p

   

 FC>1.45

3 (37.5%)

5 (62.5%)

0.013

 FC<1.45

24 (85.7%)

4 (14.3%)

 

miR-4467

   

 FC>1.75

3 (42.9%)

4 (57.1%)

0.0497

 FC<1.75

24 (82.8%)

5 (17.2%)

 
  1. Abbreviations: FC, fold change; EC, endometrial cancer; FFPE, formalin-fixed paraffin-embedded; LN, lymph node.